Half-year report · Q2
2914.TEDINET S100U5FE
Period2024-01-01 → 2024-06-30
Filed2024-08-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.57T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥829.6bn | 2024-04-01 → 2024-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.84T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.39T | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥727.5bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥432.7bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥216.8bn | 2024-04-01 → 2024-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥413.6bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥207.2bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥399.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥197.8bn | 2024-04-01 → 2024-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥621.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥373.4bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥190.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥305.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥147.9bn | 2024-04-01 → 2024-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥482.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥287.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥142.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥307.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥149.4bn | 2024-04-01 → 2024-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥485.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥288.5bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥143.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥7.87T | at 2024-06-30 | Cons. | Assets IFRS |
| Total assets | ¥7.28T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥6.97T | at 2023-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.34T | at 2024-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.37T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥4.53T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.91T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.95T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥4.44T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.83T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥1.09T | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.04T | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥827.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥260.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥567.0bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥206.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥28.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥126.1bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥102.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥267.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥270.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥163.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥171.89 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥83.3 | 2024-04-01 → 2024-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥271.69 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥161.7 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥80.18 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥171.86 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥83.29 | 2024-04-01 → 2024-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥271.63 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥161.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.16 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 56.4% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 52.6% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.5% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥658m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-06-30 | ¥336m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-06-30 | ¥803m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥27.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥27.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥25.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-06-30 | −¥16.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-06-30 | −¥16.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-06-30 | −¥16.0bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-06-30 | −¥929m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-06-30 | −¥929m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | ¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | ¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | ¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-06-30 | ¥1m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-06-30 | ¥1m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-06-30 | ¥1m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥44.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2024-04-01 → 2024-06-30 | ¥20.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥44.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2024-04-01 → 2024-06-30 | ¥20.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥154m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥154m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥154m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥73.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2024-04-01 → 2024-06-30 | ¥38.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥73.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2024-04-01 → 2024-06-30 | ¥38.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥13m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2024-04-01 → 2024-06-30 | ¥7m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.3bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.45T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2024-04-01 → 2024-06-30 | ¥770.5bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.45T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2024-04-01 → 2024-06-30 | ¥770.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥182m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2024-04-01 → 2024-06-30 | ¥119m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥472.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥472.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥449.6bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥240.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥240.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2024-04-01 → 2024-06-30 | ¥230.4bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥1.57T |
| —segment total | revenue | 2024-04-01 → 2024-06-30 | ¥829.4bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥1.57T |
| —segment total | revenue external | 2024-04-01 → 2024-06-30 | ¥829.2bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥196m |
| —segment total | revenue intersegment | 2024-04-01 → 2024-06-30 | ¥126m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥480.5bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥480.5bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥458.0bn |
| —segment total | segment profit | 2024-04-01 → 2024-06-30 | ¥242.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-06-30 | ¥242.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-06-30 | ¥232.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥711m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥268m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥783m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥18.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥8.1bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥8m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥666.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥666.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥151m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥90m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥418.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥209.6bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥727.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥727.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥167m |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥98m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥432.2bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥215.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,162
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating profit loss IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -8087000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_ReconcilingItemsMember | 9000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration | 207151000000 | JPY |
| Finance income IFRS | Prior1QuarterDuration | 9511000000 | JPY |
| Finance costs IFRS | Prior1QuarterDuration | 26378000000 | JPY |
| Profit loss before tax IFRS | Prior1QuarterDuration | 190284000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 240222000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 154000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 2345000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 242720000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -16350000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_ReconcilingItemsMember | 1000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration | 226370000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 13302000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 13302000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_ReconcilingItemsMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration | 13302000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 3132000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 3132000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 849000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration | 3981000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | -336000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 4000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_ReportableSegmentsMember | -332000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 537000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration | 205000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 230387000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 154000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 2341000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 232881000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -16038000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_ReconcilingItemsMember | 1000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration | 216843000000 | JPY |
| Finance income IFRS | CurrentQuarterDuration | 16608000000 | JPY |
| Finance costs IFRS | CurrentQuarterDuration | 35644000000 | JPY |
| Profit loss before tax IFRS | CurrentQuarterDuration | 197807000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-08-02 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第40期中（自 2024年１月１日 至 2024年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本たばこ産業株式会社 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |